Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 10—October 2019
Dispatch

Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012

Laura A. VonnahmeComments to Author , Maryam B. Haddad, and Thomas R. Navin
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure

Estimated prevalence of previous tuberculosis treatment among persons tested for tuberculosis infection, United States, 2011–2012. Boxes represent prevalence estimates and corresponding horizontal lines represent 95% CIs. IGRA, interferon-γ release assay; TST, tuberculin skin test; +, positive; −, negative.

Figure. Estimated prevalence of previous tuberculosis treatment among persons tested for tuberculosis infection, United States, 2011–2012. Boxes represent prevalence estimates and corresponding horizontal lines represent 95% CIs. IGRA, interferon-γ release assay; TST, tuberculin skin test; +, positive; −, negative.

Main Article

Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external